Therefore, pharmacological and/or dietary strategies able to restore adiponectin expression and secretion by improving inflammation-associated adipocyte dysfunction might beneficially impact several obesity-related metabolic and cardiovascular complications. The gene discussed is ADIPOQ; the disease is Obesity.